An Army base in Alaska responsible for protecting the U.S. homeland from nuclear missile attack has struggled to feed its ...
Altimmune recently announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to pemvidutide, its balanced 1:1 glucagon/GLP-1 dual agonist, for treating metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback